Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia

Arwa Z. Al-Riyami, Monika Hudoba, Sean Young, Donna Forrest*

*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sorafenib is effective for imatinib-resistant FIP1L1/PDGFRA T674I mutation-positive acute myeloid leukemia with eosinophilia'. Together they form a unique fingerprint.